Merck & CompanyvsPrivia Health

MRK and PRVA stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$145.86

Value $361B

-1.19%
MRK's page

PRVA

Privia Health Group, Inc.

$25.12

Value $3.1B

+2.34%
PRVA's page

Merck & Company (MRK) has a market value of $361B and Privia Health (PRVA) $3.1B. Over the last year, with dividends, MRK moved +61.8% and PRVA +7.2%. The P/E is 147.0 for MRK and 89.4 for PRVA. Dividend yield: MRK 2.33%, PRVA none.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$361B

    PRVA$3.1B

    MRK is 116 times PRVA

  • Revenue, 12 months

    MRK$67.4B

    PRVA$2.4B

    MRK is 28 times PRVA

  • Net income, 12 months

    MRK$2.5B

    PRVA$35M

    MRK is 71 times PRVA

  • Operating margin

    MRK–

    PRVA2.1%

  • ROIC

    MRK3.9%

    PRVA4.2%

    0.3 points apart

  • P/E

    MRK147.0

    PRVA89.4

    MRK is 1.6 times PRVA

  • Dividend yield

    MRK2.3%

    PRVA0.0%

    2.3 points apart

  • 5-year return

    MRK+103.2%

    PRVA-15.6%

    118.8 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+103.2%

PRVA-15.6%

5010015020020222023202420252026
Returns by period
PeriodMRKWith dividendsPRVAWith dividends
1 year since November 14, 2025+61.8%Price +57.1%+7.2%Price +7.2%
3 years since November 16, 2023+56.9%+16.2% a yearPrice +43.2%+9.9%+3.2% a yearPrice +9.9%
5 years since November 15, 2021+103.2%+15.2% a yearPrice +74.5%-15.6%-3.3% a yearPrice -15.6%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanyPRVAPrivia Health

Valuation

MRKPRVA
Valuation
Price$145.86$25.12
Market value$361B$3.1B
Enterprise value (EV)$405B$2.7B
P/E147.089.4
P/E, 5-year median14.8–
P/B8.03.8
EV/EBIT85.052.2
Free cash flow yield4.1%–

Results and growth

MRKPRVA
Results and growth
Revenue, 12 months$67.4B$2.4B
Net income, 12 months$2.5B$35M
Free cash flow, 12 months$14.7B–
Earnings per share, 12 months$0.98$0.26
Revenue growth, year on year1.3%22.3%
Revenue growth a year, past+9.4%over 5 years+21.0%over 5 years
EPS growth a year, past+21.2%over 5 years-11.4%over 5 years

Margins and returns on capital

MRKPRVA
Margins and returns on capital
Gross margin71.8%–
Operating margin–2.1%
Net margin3.6%1.4%
ROIC3.9%4.2%
ROE5.2%4.6%

Balance sheet

MRKPRVA
Balance sheet
Cash$9.7B$446M
Total debt$53.8B$8.3M
Net debt / EBITDA5.7-7.3
Interest cover2.4×–

Dividends and buybacks

MRKPRVA
Dividends and buybacks
Dividend yield2.3%–
Dividend per share, 12 months$3.40–
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.4%–
Shareholder yield3.7%–

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or PRVA

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or Privia Health?

By market value, Merck & Company ($361B) is about 116.0 times Privia Health ($3.1B), at today's prices.

How did MRK and PRVA stock do over the last 5 years?

Since November 15, 2021, MRK's price moved +74.5% and PRVA's -15.6%. With dividends: MRK +103.2% (+15.2% a year), PRVA -15.6% (-3.3% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or PRVA?

The dividend yield at today's price is 2.33% for Merck & Company and none for Privia Health. Over the last twelve months they paid $3.40 and – per share.

What is the P/E of MRK and PRVA?

At today's price, the P/E is 147.0 for MRK and 89.4 for PRVA. It is the share price over the last twelve months' earnings per share.

Which has the higher profit margins, Merck & Company or Privia Health?

Over the last twelve months, the net margin was 3.6% for Merck & Company and 1.4% for Privia Health, and the operating margin – and 2.1%. Revenue was $67.4B and $2.4B.

Which is the better investment, Merck & Company or Privia Health?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.